Your browser doesn't support javascript.
loading
Efficient opto- and chemogenetic control in a single molecule driven by FRET-modified bioluminescence.
Björefeldt, Andreas; Murphy, Jeremy; Crespo, Emmanuel L; Lambert, Gerard G; Prakash, Mansi; Ikefuama, Ebenezer C; Friedman, Nina; Brown, Tariq M; Lipscombe, Diane; Moore, Christopher I; Hochgeschwender, Ute; Shaner, Nathan C.
Afiliação
  • Björefeldt A; Central Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
  • Murphy J; Brown University, Department of Neuroscience, Providence, Rhode Island, United States.
  • Crespo EL; University of Gothenburg, Institute of Neuroscience and Physiology, Department of Physiology, Gothenburg, Sweden.
  • Lambert GG; Brown University, Department of Neuroscience, Providence, Rhode Island, United States.
  • Prakash M; Central Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
  • Ikefuama EC; Central Michigan University, Biochemistry, Cell, and Molecular Biology Graduate Program, Mount Pleasant, Michigan, United States.
  • Friedman N; University of California, San Diego, School of Medicine, Department of Neurosciences, La Jolla, California, United States.
  • Brown TM; Central Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
  • Lipscombe D; Central Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
  • Moore CI; Central Michigan University, Neuroscience Graduate Program, Mount Pleasant, Michigan, United States.
  • Hochgeschwender U; Brown University, Department of Neuroscience, Providence, Rhode Island, United States.
  • Shaner NC; Central Michigan University, College of Medicine, Mount Pleasant, Michigan, United States.
Neurophotonics ; 11(2): 021005, 2024 Apr.
Article em En | MEDLINE | ID: mdl-38450294
ABSTRACT

Significance:

Bioluminescent optogenetics (BL-OG) offers a unique and powerful approach to manipulate neural activity both opto- and chemogenetically using a single actuator molecule (a LuMinOpsin, LMO).

Aim:

To further enhance the utility of BL-OG by improving the efficacy of chemogenetic (bioluminescence-driven) LMO activation.

Approach:

We developed novel luciferases optimized for Förster resonance energy transfer when fused to the fluorescent protein mNeonGreen, generating bright bioluminescent (BL) emitters spectrally tuned to Volvox Channelrhodopsin 1 (VChR1).

Results:

A new LMO generated from this approach (LMO7) showed significantly stronger BL-driven opsin activation compared to previous and other new variants. We extensively benchmarked LMO7 against LMO3 (current standard) and found significantly stronger neuronal activity modulation ex vivo and in vivo, and efficient modulation of behavior.

Conclusions:

We report a robust new option for achieving multiple modes of control in a single actuator and a promising engineering strategy for continued improvement of BL-OG.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article